Premium
Migraine management: an update for the 2020s
Author(s) -
Eller Michael,
Cheng Shuli
Publication year - 2022
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.15843
Subject(s) - triptans , medicine , migraine , intensive care medicine , quality of life (healthcare) , ethnic group , socioeconomic status , psychiatry , environmental health , nursing , population , sociology , anthropology
Migraine is a common malady cutting across socioeconomic and ethnic divides in Australia. It is typically diagnosed late with significant impact on quality of life. Management options have emerged over the past several years that promise simpler treatment regimens with less potential for side‐effects. The development of rationally designed migraine preventives is the most significant advance in treatment since the development of the triptans and delivers significant hope to many headache sufferers.